CARB-X
company
About
CARB-X is a biopharmaceutical business enterprise that specializes in biotechnology, antibiotics, vaccines, fast diagnostics.
- 11 - 50
Highlights
Details
- Founded date
- Jul 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Accelerate
Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.
Investments
Number of Investments
Number of Lead Investments
3
3
CARB-X has made 3 investments. Their most recent investment was on
Feb 1, 2021, when Avails Medical raised $2.50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Feb 1, 2021
Avails Medical
|
Grant | $2.50M | Health Care | Yes |
|
Aug 11, 2020
Evotec
|
Grant | $2.91M | Biopharma | Yes |
|
Oct 1, 2019
Trellis Bioscience
|
Grant | $3.20M | Biotechnology | Yes |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
